Company: INDP
Filing Date: 2025-02-12
Form Type: S-1
Source: 0001493152-25-006068
Chunk: 133

Company: Indaptus Therapeutics, Inc.
Filing Date: 2025-02-12
Form: S-1
Chunk 133
---
-employee directors. Instead, in accordance with SEC rules, these amounts reflect the grant date fair value of stock options granted to our non-employee directors during the fiscal year ended December 31, 2024, as computed in accordance with Financial Accounting Standard Board Accounting Standards Codification Topic 718 for stock-based compensation transaction. As required by SEC rules, the amounts shown exclude the impact of estimated forfeitures related to service-based vesting conditions. Assumptions used in the calculation of these amounts are included in Note 5 to our consolidated financial statements included in our Quarterly Report on Form 10-Q for the nine month period ended September 30, 2024, which was filed with the SEC on November 12, 2024. Our non-employee directors who have received options will only realize compensation with regard to these options to the extent the trading price of our common stock is greater than the exercise price of such options. As of December 31, 2024, our non-employee directors held the following numbers of stock options: Dr. Pomerantz, 182,000 stock options; Ms. Karah 53,781 stock options, Mr. Maddaluna 53,500 stock options, Mr. Hayes 53,500 stock options, Mr. Martell 32,500 stock options, and Dr. Gilbert 58,750 stock options.

Pursuant to our director compensation policy, the annual retainer for non-employee directors is $50,000 and the annual retainer for the chair of the Board of Directors is $150,000. Annual retainers for committee membership are as follows:

| Audit                                
 committee chairperson                |     | $ | 15,000 |
| Audit                                
 committee member                     |     | $ |  7,500 |
| Compensation                         
 committee chairperson                |     | $ | 10,000 |
| Compensation                         
 committee member                     |     | $ |  6,000 |
| Nominating                           
 committee chairperson                |     | $ |  8,000 |
| Nominating                           
 committee member                     |     | $ |  5,000 |
| Scientific                           
 and technology committee chairperson |     | $ |  8,000 |
| Scientific                           
 and technology committee member      |     | $ |  4,000 |

These fees are payable in advance in four equal quarterly installments during the first week of each quarter, provided that the amount of such payment will be prorated for any portion of such